Thymectomy for non-thymomatous myasthenia gravis: a comparison of surgical methods and analysis of prognostic factors

被引:67
作者
Lin, Mong-Wei [1 ]
Chang, Yih-Leong [2 ]
Huang, Pei-Ming [1 ]
Lee, Yung-Chie [1 ]
机构
[1] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Surg, Taipei 10002, Taiwan
[2] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Pathol, Taipei 10002, Taiwan
关键词
Myasthenia gravis; Thymectomy; Video-assisted thoracoscopic surgery; ASSISTED THORACOSCOPIC THYMECTOMY; TRANSSTERNAL THYMECTOMY; AUTOIMMUNE MYASTHENIA; EXTENDED THYMECTOMY; THORACIC-SURGERY; EXPERIENCE; STANDARDS;
D O I
10.1016/j.ejcts.2009.05.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: While thymectomy is an accepted treatment for myasthenia gravis (MG), video-assisted thoracoscopic surgery (VATS) thymectomy has recently become a popular surgical treatment, especially for non-thymomatous MG (NTMG). This study aims to compare the results of VATS thymectomy and trans-sternal thymectomy, and identify prognostic factors in NTMG patients after thymectomy. Methods: A 10-year retrospective review (January 1995 to December 2004) of 60 consecutive thymectomies (22 trans-sternal thymectomies and 38 VATS thymectomies) of NTMG patients performed in a university teaching hospital was undertaken. Results: There were 43 female patients and 17 male patients with a median MG-onset age of 25 years (range: 5-78 years). Median follow-up time was 44 months. VATS thymectomy patients had a shorter hospital stay than the trans-sternal thymectomy patients (5.6 days vs 8.1 days, p = 0.008). There was no other statistically significant difference between the two operative methods in NTMG patients, including intensive care unit (ICU) stay, ventilator support time, operative time, postoperative status, complete stable remission (CSR) rate, morbidity and mortality. Three prognostic factors associated with better remission rate were hyperthyroidism (p = 0.003), age <40 years (p = 0.022) and the presence of thymic hyperplasia (p = 0.041). Other factors, including gender, disease duration, preoperative MG severity, acetylcholine receptor antibody, perioperative therapy and operative methods (32% vs 36%, p = 0.91, 95% confidence interval (CI) = 0.27-3.21) were not statistically relevant to better remission rate. Conclusions: VATS thymectomy is more advantageous for NTMG patients because of shorter hospital stay, less tissue injury, better cosmetic result and equivalent CSR rate. NTMG patients aged <40 years with hyperthyroidism and a histologic diagnosis of lymphofollicular hyperplasia have better chances of remission after thymectomy. (C) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 25 条
[1]  
[Anonymous], CLIN NEUROLOGY
[2]   Predictors of outcome in thymectomy for myasthenia gravis [J].
Budde, JM ;
Morris, CD ;
Gal, AA ;
Mansour, KA ;
Miller, JI .
ANNALS OF THORACIC SURGERY, 2001, 72 (01) :197-202
[3]  
COOPER DE, 1988, CLIN ORTHOP RELAT R, P33
[4]   MEDICAL PROGRESS - MYASTHENIA-GRAVIS [J].
DRACHMAN, DB .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (25) :1797-1810
[5]   Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology [J].
Gronseth, GS ;
Barohn, RJ .
NEUROLOGY, 2000, 55 (01) :7-15
[6]   Factors influencing the outcome of transsternal thymectomy for myasthenia gravis [J].
Huang, CS ;
Hsu, HS ;
Huang, BS ;
Lee, HC ;
Kao, KP ;
Hsu, WH ;
Huang, MH .
ACTA NEUROLOGICA SCANDINAVICA, 2005, 112 (02) :108-114
[7]   Myasthenia gravis - Recommendations for clinical research standards [J].
Jaretzki, A ;
Barohn, RJ ;
Ernstoff, RM ;
Kaminski, HJ ;
Keesey, JC ;
Penn, AS ;
Sanders, DB .
NEUROLOGY, 2000, 55 (01) :16-23
[8]  
JARETZKI A, 1988, J THORAC CARDIOV SUR, V95, P747
[9]  
Jaretzki Alfred Iii, 1997, Neurology, V48, pS52
[10]  
Kondo K, 1997, Nihon Kyobu Shikkan Gakkai Zasshi, V35, P900